ClinicalTrials.gov
public full text
Public Domain
Efficacy of Methyl Aminolevulinate + Daylight in Patients With Facial Photodamage
Treatment of actinic damage has included multiple procedures but to date there is limited scientific evidence to support the preferential use of one of these therapies according to their efficacy, safety and pain tolerance by patients. This study aims to assess the efficacy of methyl aminolevulinate + daylight vs placebo + daylight to treat facial photodamage
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study of Daylight Photodynamic Therapy With Aminolevulinic Acid for Actinic Keratoses#1171787
- A Comparison of White-light and Daylight Topical Methyl 5-aminolaevulinic Acid Photodynamic Therapy for Actinic Keratoses#875834
- Treatment of Actinic Keratoses With Photodynamic Therapy Using Sunlight Versus Red Light#911287
- Protocols for Painless Photodynamic Therapy (PDT) of Actinic Keratoses#1172478
- Daylight Photodynamic Therapy for Actinic Keratosis#851762
Record · ID 1182349
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive